(Fighting New Coronary Pneumonia) Merkel has received a second dose of vaccine AstraZeneca mixed with Modena
China News Agency, Berlin, June 23 (Reporter Peng Dawei) The spokesperson of the German Federal Government stated on the 22nd that German Chancellor Merkel had received a second dose of the new crown vaccine. She did not continue to receive the AstraZeneca vaccine for the second dose, but instead received the Modena vaccine.
On April 16 this year, Merkel received the first dose of AstraZeneca vaccine and demonstrated her vaccination certificate to the public through social media, emphasizing that vaccines are the key to defeating the epidemic.
On the 22nd of this month, the spokesperson of the German Federal Government told Deutsche News Agency upon inquiry that Merkel had completed the second dose of vaccination a few days ago. According to reports, Merkel’s second dose of vaccination was the new crown vaccine developed by Modena in the United States. The spokesperson did not explain the reason why the 66-year-old Merkel used the two different vaccines to mix.
As of that day, 67.1 million doses of the vaccine have been vaccinated in Germany, and 26,274,154 people have been fully vaccinated, accounting for 31.6% of the total population. In recent days, the domestic epidemic situation in Germany has continued to improve. The disease control agency announced on the same day that the number of newly confirmed infections with the new crown virus and the number of new deaths were 455 and 77 respectively. As of 22:00 local time on the 22nd of the German “Times Online”, a total of 3,730,797 people have been diagnosed and 9,115 people have died in Germany.
In response to the sharp rebound of the domestic epidemic in the United Kingdom, the upcoming European Cup football match final in London has raised concerns. Merkel did not explicitly support the change of venue as the Italian Prime Minister Draghi, who visited Germany a few days ago, but emphasized, She hopes UEFA can make a responsible decision.
The delta strain that has recently spread widely in the UK and other places has also raised concerns in Germany about the effectiveness of the new crown vaccine against variant strains. In this regard, Sha Xin, CEO of German BioNTech, which co-developed the new crown vaccine with Pfizer, said on the same day that there is no evidence so far that it is necessary to update the Pfizer-BioNTech new crown vaccine due to the currently circulating mutant strains. (Finish)
.